Seer (SEER) vs Voyager Therapeutics (VYGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Seer (SEER) has outperformed Voyager Therapeutics (VYGR) over the past year, losing 6.0% versus a loss of 61.6%. Over five years, VYGR leads with a -49.9% price change compared with -93.9% for SEER. Voyager Therapeutics is the larger company by market cap ($117.1 million vs $112.4 million), about 1.0 times the size, while Seer is growing revenue faster (+17.0% vs -49.5%).
Voyager Therapeutics converts more of its revenue into profit, with a net margin of -296.5% versus -444.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SEER | VYGR |
|---|---|---|
| Share price | $2.03 | $1.90 |
| Market cap | $112.41M | $117.07M |
| 1-day change | -0.49% | -7.77% |
| YTD return | +10.93% | -51.65% |
| 1-year return | -6.02% | -61.62% |
| 5-year return | -93.94% | -49.87% |
| EPS (TTM) | $-1.22 | $-1.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $16.58M | $40.37M |
| Revenue growth (YoY) | +16.99% | -49.53% |
| Net income (latest FY) | $-73.60M | $-119.72M |
| Gross margin | 51.06% | — |
| Operating margin | -470.45% | -326.56% |
| Net margin | -443.96% | -296.53% |
| 52-week high | $2.41 | $5.48 |
| 52-week low | $1.55 | $1.89 |
| Distance from 52-week high | -15.77% | -65.33% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +97.04% | +683.68% |
| Average volume | 469.41K | 578.54K |
| Shares outstanding | 55.37M | 61.62M |
| Employees | 124 | 141 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SEER has outperformed VYGR by 55.6 percentage points over the past year.
- Voyager Therapeutics is more profitable, keeping -296.5 cents of every revenue dollar as net income versus -444.0 cents for Seer.
- Seer grew revenue faster in its latest fiscal year (+16.99% vs -49.53%).
- The two companies sit in different sectors: Seer in Industrials and Voyager Therapeutics in Health Care.
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
About Voyager Therapeutics
VYGR stock →Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 141 employees
SEER vs VYGR FAQ
Which is bigger, Seer or Voyager Therapeutics?
Voyager Therapeutics (VYGR) is larger, with a market capitalization of $117.07M compared with $112.41M for Seer (SEER).
Which stock has performed better over the past year, SEER or VYGR?
SEER returned -6.02% over the past 12 months, compared with -61.62% for VYGR (price return, excluding dividends). Past performance does not predict future results.
Are Seer and Voyager Therapeutics in the same industry?
No. Seer is in the Industrials sector, while Voyager Therapeutics is in Health Care.